Leaders in the field give the latest updates on trials, research, and recommendations for clinical care in kidney cancer. Don't miss this expert summary on the important research this year and hear their discussion on how we might see the clinical landscape changing.

Great panel of topics and speakers!! Brian Rini, MD: Summary of first-line trials, Thomas Powles, MBBS, MRCP, MD: Adjuvant trials in RCC, Martin Voss, MD: Summary of 2nd line trials and beyond, Laurence Albiges, MD, PhD: Microbiome, Sumanta Pal, MD: Non-clear cell, Rana McKay, MD: Novel drugs in early development.

свернуть